Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5

Yue Huang,Jingli Yan,Qi Li,Jiafei Li,Shouzhe Gong,Hu Zhou,Jianhua Gan,Hualiang Jiang,Gui-Fang Jia,Cheng Luo,Cai-Guang Yang
DOI: https://doi.org/10.1093/nar/gku1276
IF: 14.9
2014-12-01
Nucleic Acids Research
Abstract:Two human demethylases, the fat mass and obesity-associated (FTO) enzyme and ALKBH5, oxidatively demethylate abundant N(6)-methyladenosine (m(6)A) residues in mRNA. Achieving a method for selective inhibition of FTO over ALKBH5 remains a challenge, however. Here, we have identified meclofenamic acid (MA) as a highly selective inhibitor of FTO. MA is a non-steroidal, anti-inflammatory drug that mechanistic studies indicate competes with FTO binding for the m(6)A-containing nucleic acid. The structure of FTO/MA has revealed much about the inhibitory function of FTO. Our newfound understanding, revealed herein, of the part of the nucleotide recognition lid (NRL) in FTO, for example, has helped elucidate the principles behind the selectivity of FTO over ALKBH5. Treatment of HeLa cells with the ethyl ester form of MA (MA2) has led to elevated levels of m(6)A modification in mRNA. Our collective results highlight the development of functional probes of the FTO enzyme that will (i) enable future biological studies and (ii) pave the way for the rational design of potent and specific inhibitors of FTO for use in medicine.
biochemistry & molecular biology
What problem does this paper attempt to address?